Moderna is terminating the development of an mRNA vaccine in congenital cytomegalovirus (CMV) after it failed to show any significant benefit in a Phase III trial. Top line data from the CMVictory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results